• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特化细胞中 NRF2 和 sulfiredoxin-1 的升高可作为特发性肺纤维化和非特异性间质性肺炎肺部氧化应激的标志物。

Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.

机构信息

Department of Medicine, University of Helsinki, Helsinki University Hospital, Finland.

出版信息

APMIS. 2010 Sep 1;118(9):703-12. doi: 10.1111/j.1600-0463.2010.02646.x.

DOI:10.1111/j.1600-0463.2010.02646.x
PMID:20718723
Abstract

Human idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) have been proposed to be attributable to oxidative stress. The nuclear factor, erythroid derived 2, like protein (NRF2)-sulfiredoxin-1 (SRX1) pathway was hypothesized to be associated with the pathogenesis of human pulmonary fibrosis. Several methods including digital morphometry were used in the assessment of the cell-specific localization and expression of NRF2 and SRX1 and selected proteins linked to their activation/stability in human IPF/usual interstitial pneumonia (UIP) and NSIP lung. The proteins of the NRF2 pathway were localized in the hyperplastic alveolar epithelium and inflammatory cells in IPF and NSIP, but were absent in the fibroblastic foci characteristic of IPF. Morphometric evaluation revealed NRF2 and KEAP1 to be significantly elevated in the hyperplastic alveolar epithelium compared with the normal alveolar epithelium, and NRF2 was remarkably expressed in the nuclear compartment of the hyperplastic cells. SRX1 was expressed mainly in alveolar macrophages, and the number of SRX1-positive macrophages/surface area was elevated in NSIP, a disease which contains more marked inflammatory reaction compared with the IPF/UIP lung. The expression of the NRF2 pathway in human IPF and NSIP is further evidence that the pathogenesis of human fibrotic lung diseases is oxidant-mediated and originates from the alveolar epithelium.

摘要

人类特发性肺纤维化 (IPF) 和非特异性间质性肺炎 (NSIP) 被认为与氧化应激有关。核因子,红系衍生 2 样蛋白 (NRF2)-硫氧还蛋白 1 (SRX1) 途径被假设与人类肺纤维化的发病机制有关。几种方法,包括数字形态计量学,被用于评估 NRF2 和 SRX1 的细胞特异性定位和表达,以及与其在人类 IPF/普通间质性肺炎 (UIP) 和 NSIP 肺中的激活/稳定性相关的选定蛋白质。NRF2 途径的蛋白质定位于 IPF 和 NSIP 的增生性肺泡上皮和炎症细胞中,但在 IPF 特有的成纤维细胞灶中不存在。形态计量学评估显示,与正常肺泡上皮相比,NRF2 和 KEAP1 在增生性肺泡上皮中显著升高,并且 NRF2 在增生细胞的核区室中显著表达。SRX1 主要在肺泡巨噬细胞中表达,并且在 NSIP 中,SRX1 阳性巨噬细胞/表面积的数量增加,与 IPF/UIP 肺相比,NSIP 具有更明显的炎症反应。NRF2 途径在人类 IPF 和 NSIP 中的表达进一步证明人类纤维性肺部疾病的发病机制是氧化应激介导的,并且起源于肺泡上皮。

相似文献

1
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.特化细胞中 NRF2 和 sulfiredoxin-1 的升高可作为特发性肺纤维化和非特异性间质性肺炎肺部氧化应激的标志物。
APMIS. 2010 Sep 1;118(9):703-12. doi: 10.1111/j.1600-0463.2010.02646.x.
2
Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype.Gremlin的定位和表达水平在一定程度上区分特发性间质性肺炎的严重程度和亚型。
J Pathol. 2008 Mar;214(4):456-63. doi: 10.1002/path.2300.
3
Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia.特发性肺纤维化、非特异性间质性肺炎和隐源性机化性肺炎患者的肺组织和血清中硫氧还蛋白1水平升高。
Intern Med. 2010;49(22):2393-400. doi: 10.2169/internalmedicine.49.4049. Epub 2010 Nov 15.
4
Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.核因子红细胞 2 相关因子 2(Nrf2)和 DJ1 是肺癌的预后因素。
Hum Pathol. 2012 Apr;43(4):577-84. doi: 10.1016/j.humpath.2011.05.024. Epub 2011 Sep 23.
5
Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.特发性间质性肺炎肺间质的炎症细胞表型分析
Respiration. 2007;74(2):159-69. doi: 10.1159/000097133. Epub 2006 Nov 14.
6
Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.特发性间质性肺炎和类风湿关节炎相关间质性肺疾病中的先天性免疫改变。
Immunol Lett. 2015 Feb;163(2):179-86. doi: 10.1016/j.imlet.2014.12.004. Epub 2014 Dec 23.
7
The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.特发性肺纤维化和非特异性间质性肺炎中上皮细胞的p53-Mdm2关联
J Clin Pathol. 2005 Jun;58(6):583-9. doi: 10.1136/jcp.2004.022632.
8
Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias.特发性间质性肺炎中肺神经营养蛋白表达增加。
Sarcoidosis Vasc Diffuse Lung Dis. 2007 Mar;24(1):13-23.
9
The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man.西部高地白梗特发性肺纤维化的组织病理学兼具人类非特异性间质性肺炎和普通间质性肺炎的特征。
J Comp Pathol. 2013 Aug-Oct;149(2-3):303-13. doi: 10.1016/j.jcpa.2013.03.006. Epub 2013 May 9.
10
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.一氧化氮肺弥散能力作为特发性间质性肺炎纤维化改变的标志物
J Appl Physiol (1985). 2016 May 1;120(9):1029-38. doi: 10.1152/japplphysiol.00964.2015. Epub 2016 Feb 18.

引用本文的文献

1
Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators.间充质干细胞外泌体通过调节免疫调节剂减轻肺纤维化。
World J Stem Cells. 2024 Jun 26;16(6):670-689. doi: 10.4252/wjsc.v16.i6.670.
2
Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges.铁死亡在肺纤维化中的新兴作用:当前观点、机遇与挑战
Cell Death Discov. 2024 Jun 24;10(1):301. doi: 10.1038/s41420-024-02078-0.
3
Deciphering the Antifibrotic Property of Metformin.解析二甲双胍的抗纤维化特性。
Cells. 2022 Dec 16;11(24):4090. doi: 10.3390/cells11244090.
4
Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches.NRF2在纤维化疾病中的作用:从机制到治疗方法
Front Physiol. 2022 Jun 3;13:889792. doi: 10.3389/fphys.2022.889792. eCollection 2022.
5
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.将氧化应激作为特发性肺纤维化的一种治疗方法
Front Pharmacol. 2022 Jan 21;12:794997. doi: 10.3389/fphar.2021.794997. eCollection 2021.
6
Irreversibility of Pulmonary Fibrosis.肺纤维化的不可逆性
Aging Dis. 2022 Feb 1;13(1):73-86. doi: 10.14336/AD.2021.0730. eCollection 2022 Feb.
7
Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches - Pulmonary Disease/Asthma.Nrf2在疾病中的作用:新的分子机制与治疗方法——肺部疾病/哮喘
Front Physiol. 2021 Sep 29;12:727806. doi: 10.3389/fphys.2021.727806. eCollection 2021.
8
Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases.罕见呼吸系统疾病中的氧化应激与内质网应激
J Clin Med. 2021 Mar 18;10(6):1268. doi: 10.3390/jcm10061268.
9
Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report.吡非尼酮和尼达尼布对特发性肺纤维化患者全身氧化应激和炎症标志物的影响:初步报告
Antioxidants (Basel). 2020 Oct 30;9(11):1064. doi: 10.3390/antiox9111064.
10
Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis.特发性肺纤维化病理生物学中的端粒异常
J Clin Med. 2019 Aug 16;8(8):1232. doi: 10.3390/jcm8081232.